Neurology Archives - Page 3 of 11

Real-world use of Ubrogepant as acute treatment for migraine with an anti-calcitonin gene-related peptide monoclonal antibody: results from COURAGE

Authors: R B Lipton, J Contreras-De Lama, D Serrano, E Engstrom, N D Ayasse, W Poh, F Cadiou, A M Adams Published: Neurology and Therapy, 2023 View publication Introduction Although acute and...

Evaluating therapeutic benefits of ubrogepant via latent class models: A post hoc exploratory analysis of the ACHIEVE I and ACHIEVE II trials

Authors: C J Iaconangelo, D Serrano, A M Adams, J M Trugman, R B Lipton Published: Headache, 2023 View publication Objective To evaluate an alternative method of defining acute treatment success in...

Opicapone versus entacapone: Head-to-head retrospective data-based comparison of healthcare resource utilization in people with Parkinson’s disease new to catechol-O-methyltransferase (COMT) inhibitor treatment

Authors: G Harrison-Jones, X Li Marston, F Morgante, K R Chaudhuri, G Castilla-Fernández, V Di Foggia Published: European Journal of Neurology, 2023 View publication Background and purpose Motor fluctuations are a significant...

The Right Measurement Frameworks Matter for Demonstrating Treatment Efficacy in Clinical Trials for Alzheimer’s Disease

Alzheimer’s disease is more than a neurodegenerative disorder. For the 6 million people living with the disease1 (and their caregivers), mild, moderate or severe symptoms are the cause of lost memories, forgotten...

Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study

Authors: A M Adams, S Hutchinson, E Engstrom, N D Ayasse, D Serrano, L Davis, K Sommer, J Contreras-De Lama, R B Lipton Published: The Journal of Headache and Pain, 2023 View...

Psychosocial health modifies associations between HPA-axis function and brain structure in older age

Authors: I F van der Velpen, M de Feijter, R Raina, F Özel, M Perry, M A Ikram, M W Vernooij, A I Luik Published: Psychoneuroendocrinology, 2023 View publication Background Dysregulation of...

Increasing Awareness for Young Onset Parkinson’s Disease Through OPEN Health’s Data-Driven Approach

Every so often as an agency you get to work on a project that truly inspires you. We were given just this type of opportunity by Spotlight YOPD, a small charity with...

Priority acute and preventive migraine treatment benefits: Results of the Migraine Clinical Outcome Assessment System (MiCOAS) qualitative study of people living with migraine

Authors: R Mangrum, M T Gerstein, C J Hall, D C Buse, C R Houts, J S McGinley, K P McCarrier, R B Lipton, R J Wirth Published: Headache: The Journal of...

Modeling monthly migraine-day distributions using longitudinal regression models and linking quality of life to inform cost-effectiveness analysis: A case study of Fremanezumab in Japanese-Korean migraine patients

Authors: X Wang, K Yamato, Y Kojima, J J Paris, E F P Peterse, M J H G Simons & C Bennison Published: PharmacoEconomics, 2023 View publication Background and Objectives As regression...

News